Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Giulio Tarro

Giulio Tarro

President, Foundation de Beaumont Bonelli for cancer research Italy

Theresa I. Dale

Theresa I. Dale

Founder & Dean, California College of Natural Medicine USA

Ananda M. Chakrabarty

Ananda M. Chakrabarty

Scientist and Professor, University of Illinois at Chicago Illinois USA

Helieh Oz

Helieh Oz

Investigator, University of Kentucky Medical Center USA

K. M. Yacob

K. M. Yacob

Marma Heatth Centre India

Durgesh Sinha

Durgesh Sinha

Temple University, Philadelphia USA

Scott Umlauf

Scott Umlauf

Senior Director, Product Development VaxInnate Corporation USA

Richard Colonno

Richard Colonno

Assembly Biosciences USA

Influenza Research 2019

About Conference


3rd International Conference on Influenza and Emerging Infectious Diseases is a unique international platform for Researchers, Young Scholars, Ecologists, Physicians, Consultants, Diagnostic Specialists, Practice Nurses, Students, Academicians, Pioneers including Clinical and Medical professionals from various fields: Microbiology, Virology, Immunology, Oncology, Ecology, Evolution, Community Health, Public Health, Hospital Health, Industries (Pharmaceutical, Vaccines, drugs, antimicrobials) and etc., to exchange the technical and conceptual knowledge need to encounter the infectious diseases and illness might be Food Borne, Water Borne, Air Borne, and etc. are cause of public health crises such as Crimean-Congo haemorrhagic fever (CCHF), Ebola virus disease, Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome (SARS), Nipah, henipaviral diseases, Rift Valley fever (RVF), Zika, HIV, AIDS and etc.

Being witnessed the triumph of Flu 2016,Organising Committee Members are delighted to announce the next event 3rdInternational Conference on Influenza & Emerging Infectious DiseasesduringApril 10-11, 2019inToronto, Canada.

This Unique international platform also facilitates

  • New research findings and scientific books can be released.
  • Collaboratewith universities, labs, research centers, industries and etc.
  • Promotionfor your own labs will be feasible.
  • Provides a platform to organize symposia or workshops
  • Special interactive sessions will be provided.

The field ofInfectious Diseases is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Selected contributions will be published in following Journals

Details of Influenza Conferences in 2019 in the USA:

Conference Name Place Date
Influenza Conference 2019 Toronto , Ontario , Canada April 10-11, 2019

Scientific Sessions

Diversified technical sessions allow to meet the accomplished people are delivering their tremendous research presentations based on the theme "Conceptual Applications to encounter the Infectious Diseases"

CONFERENCE HIGHLIGHTS

  • Influenza & Infectious Diseases
  • Fungal Infectious Diseases
  • Infectious Disease Epidemiology
  • Clinical Infectious Diseases
  • Pathological Studies
  • Bacterial Infectious Diseases
  • Antimicrobial Resistance and Infectious Diseases
  • Viral Infectious Diseases
  • Cancer & infections
  • Hospital (Healthcare) Acquired Infectious Diseases
  • Pediatric Infectious Diseases
  • Gastrointestinal Infectious Diseases
  • Diagnosis and Treatment for Infectious Diseases
  • Sexually Transmitted Infectious Diseases
  • Neurological Infectious Diseases
  • Dermatological Infectious Diseases
  • Pulmonary Infectious Diseases
  • Ophthalmological Infectious Diseases
  • Zoonotic Diseases
  • Antigenic Variation of Flu/ Influenza Virus
  • Public Health Research
  • Case studies on Infectious Diseases
  • Treatment for Infectious Diseases
  • Coinfection: Multi Pathogen Infectious Diseases
  • Non Communicable Diseases (NCDs)
  • Foodborne Illness Infectious Diseases
  • Nutritional Supplements and Herbal Medicines
  • Rion Infectious Diseases
  • Emerging Protozoan Pathogens Infectious Diseases

Related Conferences:

5th Annual Congress on Rare Diseases and Orphan Drugs, August 29-30, 2018 Boston, USA, 5th International Conference on Neglected Tropical & Infectious Diseases, August 29-30, 2018 Boston, USA, 4th International Conference on Infection, Disease Control & Prevention, May 17-18, 2019 Philadelphia, Pennsylvania, USA, 4th Annual Congress on Infectious Diseases, August 29-30, 2018 Boston, USA, 7th International Conference and exhibition on Bacteriology & Antibiotics, April 24-25, 2019 Vancouver, Canada

11th International Conference on Rare Diseases and Orphan Drugs (ICORD), September 13-16, 2018   Johannesburg, South Africa;  Orphan Drugs Summit, September 2018, The Netherlands; SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference, 18–19 October 2017 London, United Kingdom

Related Societies:

USA: AIDS Healthcare Foundation, Centre for AIDS Research, Northland Cares, Arizona, The McGregor Clinic, Inc., Canadian Public Health Association, Tropical Pathology & Infectious Diseases Associations, International Society for Infectious Diseases, AIDS United, HIV.gov, AmfAR, UNAIDS, The Elizabeth Taylor AIDS Foundation, International AIDS Society, International HIV/AIDS Alliance, Addiction Research and Treatment Corporation, AIDS Community Research Initiative of America, Albert Einstein College of Medicine, Community Healthcare Network, Elmhurst Hospital Center, Evergreen AIDS Foundation, Lifelong AIDS Alliance

EuropeEuropean Society for Clinical Microbiology and Infectious Diseases,  British Society for Antimicrobial ChemotherapySociety for General Microbiology

Asia PacificHuman Genetics Society of AustralasiaGenetics Society of JapanNDC Medicine.

Market Analysis Report

Infectious Disease Therapeutics Market (drugs & vaccine) was valued at US$ 105.13 Billion in 2018 and expected to reach USD 179.70 Billion by the end of 2025 with a growing potential of 7.96 %.

Top 6 Infectious Diseases (HIV, malaria, hepatitis, influenza, Human Papillomavirus (HPV), and tuberculosis) therapeutics market worth $86.2 Billion By 2025

The global Influenza therapeutics market was valued USD 1699.7 Million in 2016, and is estimated to reach US$ 2012.6 Million by 2025, with a growth potential of 1.4% 

Major factors those are driving the growth of the market:

  • Increasing the occurrence of infectious diseases
  • Growing use of direct acting anti-viral
  • Increasing healthcare expenditure
  • Increasing geriatric population,
  • Growing healthcare awareness
  • Increasing government funding’s in developing countries.
  • The major factor restraining the growth of the market is generic erosion, Patent expiration of infectious disease drugs.

Regional wise Infectious disease Therapeutics Market

  • North America: USA & Canada
  • Europe: Germany, UK, France, Spain, Italy, Nordic countries, Benelux, Poland & Russia
  • Asia Pacific: China, India, Japan, ASEAN, Australia, and New Zealand
  • Latin America: Brazil & Mexico
  • Middle East & Africa: GCC, Southern Africa, North Africa

Therapeutics

  • Anti-infective drugs: Antibacterial, antifungal, antiparasitic, and antiviral drugs are some of the anti-infective drugs used for the treatment of infectious diseases.
  • Vaccines

End users:

  • Pediatrics
  • Adolescence
  • Adults
  • Elderly

Disease type therapeutics market  

HIV

  • Emtriva
  • Aptivus
  • Isentress
  • Lexiva/Telzir
  • Selzentry
  • Tivicay
  • Atripla
  • Complera
  • Genvoya
  • Odefsey
  • Stribild
  • Truvada
  • Triumeq
  • Descovy
  • Vitekta

Influenza

  • Relenza
  • Tamiflu
  • Rapivab

TB

  • Sirturo

Malaria

  • Coartem

HPV

Hepatitis

Key Players of Infectious disease Therapeutics Market

  • Abbott Laboratories
  • AbbVie, Astellas Pharma
  • Achillion Pharmaceuticals
  • Astrazeneca PLC
  • AstraZeneca, Auritec Pharmaceuticals
  • Bayer
  • Biocryst Pharmaceuticals Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Chimerix Pharmaceuticals
  • Chiron Corporation
  • CSL Limited
  • Cubist, Eli Lilly
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche AG
  • Gilead Sciences
  • Gilead Sciences, Inc.
  • Glaxosmithkline PLC
  • Isis Pharmaceuticals
  • Janssen Pharmaceutical
  • Johnson & Johnson
  • Pfizer
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Nanotherapeutics Inc.
  • Novartis International AG
  • Protein Sciences Corporation
  • pSivida
  • Roche Holding AG
  • Sanofi SA
  • Shionogi & Co. Ltd.
  • Sinovac Biotech Ltd.

Reference:

Visa Information

 

Issue with VISA!!

Are you planning to have a professional and delightful trip to Toronto, Canada???

We believe you must be having a query regarding your Visa to Visit as a Speaker/Delegate, Tourist or Business Person at Toronto, Canada. Influenza Research Committee will be happy to help you in all regards to plan your trip to Toronto, Canada. Here is the simplest way to know the process for your Visa Approval. Kindly drop us an email at . Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA. Processing time for visa applications vary depending on the office and the time of the year. Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications, including all supporting documents.

 

Past Conference Report

Flu-2016

Conference series llc LTD hosted the “2nd International Conference on Flu” during October 31-November 02, 2016 at DoubleTree by Hilton Hotel San Francisco Airport, San Francisco, USA with the theme Scientific Milestones in Understanding and Preventing Flu” where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Immunologists, Virologists, scientists, researchers, students and leaders in Flu Research, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Flu Vaccines: Current and Novel Approach
  • Pathology of Influenza Virus Infections
  • Flu Symptoms & Treatment
  • Antivirals and Therapeutics
  • Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups
  • Flu Virus -Advancements in Detection & Differentiation
  • Flu: Immunology & Genetics
  • Flu Clinical Studies & Case Reports
  • Epidemiology and Public Health of Influenza
  • Surveillance Issues and Burden of Disease

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Notable Keynotes:

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Honorable Moderator Jun Wang, University of Arizona, USA and Sunil K Lal, Monash University, Malaysia for his remarkable contribution towards smooth functioning at Flu-2016 Conference.

Conference Sessions Chairs:      

For further information visit : Flu 2016

Conference Series llc LTD offers its heartfelt appreciation to Societies and Organizations includes Allied AcademiesAndrew John Publishing Inc., New York Private Equity Forums and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series llc LTD in supporting and making the conference a never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph Flu-2016, Conference Series llc LTD is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, "3rd International Conference on Flu & Emerging Infectious Diseases" to be held during September 17-18, 2018 at San Diego, USA.

Let us meet again @ Flu-2018


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 10-11, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Virology & Mycology

Journal of Virology & Antiviral Research

Journal of Vaccines & Vaccination

Journal of Clinical & Cellular Immunology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration

Collaboration

Collaboration

Collaboration

Collaboration

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos

Keytopics

  • Antivirals And Therapeutics For Flu Disease
  • Bird Flu Vaccine
  • Case Reports Of Flu
  • Cold And Flu Prevention
  • Cold Flu
  • Cold Symptoms
  • Different Flu Shots
  • Different Flu Vaccines
  • Emerging Infectious Diseases
  • Flu Diagnosis
  • Flu Disease
  • Flu Immunization
  • Flu Injection
  • Flu Shot
  • Flu Shot Immunization
  • Flu Symptoms And Treatment
  • Flu Treatment
  • Flu Vaccine
  • Flu Vaccine Effectiveness
  • Flu Vaccine For Children
  • H1N1 Flu Vaccine
  • Infant Flu Shot
  • Infection Control
  • Infection Control And Hospital Epidemiology
  • Infection Control In Dentistry
  • Infection Control In Healthcare
  • Infection Control Risk Assessment
  • Infection Control Surveillance
  • Infection Control Techniques
  • Infectious Disease Control
  • Infectious Disease Research
  • Influenza Immunization
  • Influenza Proteins
  • Influenza Shot
  • Influenza Vaccine
  • Influenza Virus Vaccine
  • Influenzavirus A
  • Influenzavirus B
  • Nasal Flu Vaccine
  • Pediatric Flu Vaccine
  • Pediatric Infectious Disease
  • Pediatrics Infectious Diseases
  • Prevention Of Infectious Diseases
  • Respiratory Flu Symptoms
  • Seasonal Flu Vaccine
  • Swine Flu Shot
  • Swine Flu Vaccine
  • Transmittable Diseases
  • Treatment Of Emerging Infectious Diseases
  • Types Of Flu Vaccines
  • Vaccinated Diseases
  • Vaccines